Atlas Trials

Efficacy and Safety of Treprostinil in Intermediate-Risk Pulmonary Arterial Hypertension

Clinical trial NCT07177703 · NOT_YET_RECRUITING

Trial details

NCT number
NCT07177703
Sponsor
Shanghai Zhongshan Hospital
Status
NOT_YET_RECRUITING
Phase
Phase 2
Study type
INTERVENTIONAL
Pulmonary Arterial Hypertension (PAH)
Start date
2025-10-31
Primary completion
2027-12-31
Enrollment
32

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.